tistically significantly increased risk of infection; the mean A1c value was 8.44% among those with infections compared with 7.80% for those without (P=.09). Forty-two (6%) of 700 patients without prior diabetes history had evidence of undiagnosed diabetes; their infection rate was comparable to that of known diabetics (3/42 [7%] vs 17/300 [6%]; P=.72). An additional 30% of nondiabetics had elevated hemoglobin A1c determinations or perioperative hyperglycemia.
CONCLUSIONS: Postoperative hyperglycemia and previously undiagnosed diabetes are associated with development of SSIs among cardiothoracic surgery patients. Screening for diabetes and hyperglycemia among patients having cardiothoracic surgery may be warranted to prevent postoperative and chronic complications of this metabolic abnormality (Infect Control Hosp Epidemiol 2001;22:607-612).
Diabetes is a known risk factor for development of surgical-site infections (SSIs) among patients having cardiothoracic procedures. [1] [2] [3] [4] [5] [6] Several studies 7, 8 have identified that perioperative hyperglycemia poses an additional risk for infection among diabetics; however, these studies do not include assessments of long-term glucose control. Certainly, it is the poor glycemic control over time that is associated with the long-term complications of the disease 9 ; yet, the role of chronic hyperglycemia as a risk factor for development of SSIs is largely unknown. Patients with poor chronic diabetic control also may be more prone to hyperglycemia with stress. Thus, the elevated glucose documented during the preoperative period may be a marker for this chronic metabolic derangement or for associated factors rather than a direct contributor to an excess risk of infection.
Approximately 50% of patients with diabetes in the United States are undiagnosed and unaware of their disease. 10 Many of these undiagnosed patients have numerous encounters with medical professionals and receive care in the hospital; yet, their diabetes is overlooked, and the opportunity to initiate therapy to reduce the risk of subsequent complications is lost. 11 In addition, the incidence of infections within this group after having cardiothoracic surgery has not been evaluated.
In this investigation, we evaluated a large group of patients having cardiothoracic procedures for evidence of previously undiagnosed diabetes, poor diabetic control, and perioperative hyperglycemia. These patients then were followed prospectively and those with subsequent SSIs identified with the following aims: (1) to define the role of previously undiagnosed diabetes in the development of SSIs; and (2) to determine the relative importance of chronic glycemic control and perioperative glucose management in the subsequent development of infection.
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METHODS
All patients referred to cardiothoracic surgeons of the Saint Thomas Heart Institute for coronary artery bypass or cardiac valve procedures were eligible for study participation. Prior to their procedures, patients were evaluated by a study nurse, and consent for hemoglobin A1c determination was obtained. For patients having emergency procedures or procedures performed when the study nurse was not immediately available, consent was obtained from them or their legal representative within 24 to 48 hours after the procedure; only serum specimens obtained preoperatively were used for hemoglobin A1c determinations in these patients.
During the time of the study, Saint Thomas Hospital performed detailed surveillance as defined by the National Nosocomial Infection Surveillance program of the Centers for Disease Control and Prevention (CDC). 12 All patients having coronary artery bypass or cardiac valvular procedures were followed prospectively to identify those developing SSIs; CDC case definitions for SSIs were used. 13 Infection control nurses (ADL, JFC) were blinded to the hemoglobin A1c values of all patients and were unaware of this information when making determinations of the presence of infection. In addition, Saint Thomas Heart Institute personnel prospectively collected information on all patients having operative procedures. Baseline demographic, clinical, and laboratory information obtained from both of these sources was used in the study.
Hemoglobin A1c determinations were performed by ion capture assay 14 on serum from 1,000 patients agreeing to participate in the study; normal values are 4.2% to 6.2%.
Two separate analyses were conducted: the hyperglycemia analysis and the hemoglobin A1c analysis. In the hyperglycemia analysis, demographic, clinical, and laboratory parameters of all cardiothoracic surgery patients with SSIs were compared with similar parameters among uninfected controls. These controls consisted of 970 patients without SSIs who had A1c determinations.
To assess the importance of glucose control among diabetics and the role of previously undiagnosed diabetes as a risk factor for SSIs, a second analysis was performed, limited to those individuals who consented to have preoperative hemoglobin A1c determinations. Among patients with infections, only 30 had preoperative hemoglobin A1c determinations and were included in this analysis; 44 patients identified through routine surveillance were excluded. Controls were the same patients used in the hyperglycemia analysis. Hemoglobin A1c values у7.0% among patients without prior history of diabetes were considered indicative of previously undiagnosed diabetes. 15 In both analyses, serum glucose values were used preferentially. If no serum glucose was available for the given risk period, fingerstick whole-blood glucose values were used. Fingerstick values accounted for 2 (0.2%) of 976 preoperative glucose values and 42 (4.3%) of 974 postoperative determinations. For 68 (6.5%) and 70 (6.7%) patients, respectively, no preoperative or postoperative glucose determinations were available. Results of the risk factor analyses were not appreciably different when performed with these patients either omitted or included with normal glucose values; results presented in this report are those obtained with these patients omitted. Preoperative and postoperative hyperglycemias were defined as serum or fingerstick whole-blood glucose values of у200 mg/dL recorded within 48 hours before or after surgery, respectively.
Student's t test was used to assess differences in the means of continuous variables; Fisher's Exact Test and the chi-square test were used to compare differences in categorical and dichotomous variables. In the hyperglycemia analysis, all statistically significant variables and those with P values р.1 were evaluated in a multivariate model using stepwise logistic regression (Stata Corp, College Station, TX). To assess the association of SSIs and the degree of hyperglycemia, the chi-square for linear trend was used. 16 The study was approved by the Saint Thomas Institutional Review Board.
RESULTS
From November 1998 through September 1999, 1,000 patients underwent cardiothoracic surgical procedures at Saint Thomas Hospital, consented to study participation, and had hemoglobin A1c determinations; 30 (3.0%) developed SSIs. Forty-four additional cardiothoracic surgery patients, not enrolled in the hemoglobin A1c evaluation, also were identified during routine surveillance as having developed SSIs. Among patients with infections, the 44 patients identified through routine sur veillance activities were similar in demographic and operative characteristics to the 30 infected patients with hemoglobin A1c determinations. These 74 infected patients included 30 with mediastinitis, 24 with chest-wound infections, and 23 with infections of saphenous-vein harvest sites; three had both thoracic-and leg-wound infections.
Hyperglycemia Analysis
The 74 infected patients and the 970 uninfected controls had several similar demographic and operative characteristics (Table 1) . Univariate analysis identified nine variables associated with development of SSIs ( Table 2) . After adjustment using logistic-regression analysis, a history of diabetes, postoperative hyperglycemia, having multiple procedures during the same procedure (coronary bypass surgery and valve replacement, coronary bypass surgery and ventricular septal defect repair, etc), and female gender remained independently associated with development of infection ( The rate of SSIs directly correlated with the degree of hyperglycemia encountered during the postoperative period ( Table 3 ). The ORs of SSIs were 2.54, 2.97, and 3.32 among patients with postoperative glucose levels of 200 to 249, 250 to 299, and 300 mg/dL or greater, respectively (compared to those with levels less than 200 mg/dL; P<.0001; Table 3 ).
Hemoglobin A1c Analysis
Among the 1,000 patients with hemoglobin A1c determinations, 300 had known diabetes and 700 had no previous diabetes diagnosis. Of the 700 not known to have diabetes, 173 (25%) had elevated hemoglobin A1c determinations (>6.2%), including 42 (6%) with undiagnosed diabetes (hemoglobin A1c у7.0%); another 213 (30%) had elevated hemoglobin A1c determinations (131 patients) or hyperglycemia during the perioperative period (82 patients; Table 4 October 2001
DISCUSSION
Several studies [1] [2] [3] [4] [5] [6] have observed an increased risk of SSIs among diabetics having cardiothoracic surger y. Similarly, we found that having a history of diabetes was associated with a 2.7-fold increase in the risk of developing a wound infection. This increased risk of infection was not clearly related to the degree of chronic glucose control during the months prior to the procedure, as measured by A1c determinations. However, acute elevations in glucose control temporally related to the surgical procedure were important. Hyperglycemia during the immediate postoperative period was an independent risk factor for developing infection among those patients with and without a history of diabetes, and the risk of infection correlated with the degree of glucose elevation. Finally, we found that a number of patients were referred for cardiothoracic procedures with evidence of diabetes but without previously having the diagnosis made or intervention begun. These patients had an increased risk of developing SSIs at a rate that was comparable to those with known diabetes.
In this report, 6% of patients without previous history of diabetes had evidence of that illness, based on elevated hemoglobin A1c determinations. A1c determinations are not included in the criteria 17 recently proposed by the American Diabetes Association for the diagnosis of diabetes mellitus. Some of these patients classified as having previously undiagnosed diabetes in this report may not fulfill these criteria if formally tested; yet, despite the proposed criteria, others 15, 18 have argued for the utility of the hemoglobin A1c determination as a diagnostic tool. Peters et al 15 found that 89% of patients with hemoglobin A1c levels of at least 7.0% had diabetes when tested with oral glucose tolerance tests, and only 3.8% had normal glucose metabolism.
The number of patients with evidence of previously undiagnosed diabetes (6%) found in this report is also consistent with the findings of the Third National Health and Nutrition Examination Survey 10 in which 2.5% to 5.7% of individuals aged 40 to >70 years old had evidence of undiagnosed disease. In that report, 10 an even larger group of patients (7.1%-14.1% within the same age groups) had impaired fasting glucose values. Among nondiabetics undergoing cardiothoracic surgery in this report, an additional 19% were found to have abnormal hemoglobin A1c values (6.3%-6.9%), and another 11% had perioperative glucose values of 200 mg/dL or greater. Husband 19 noted that 63% of patients without a previous history of diabetes who were admitted with myocardial infarction and subsequently noted to have "stress hyperglycemia" (serum glucose у180 mg/dL) were found ultimately to have diabetes when formally tested; thus, it is very likely that most, if not all, of the patients with previously undiagnosed diabetes in this report indeed had diabetes, and their diagnosis had not been detected before they presented for cardiothoracic procedures. It also is quite possible that many of the individuals with abnormal A1c values or hyperglycemia in this report would have impaired fasting glucose values once adequately evaluated and may be at risk to develop diabetes and its complications. 10, 20 Certainly, patients with elevated hemoglobin A1c values and documented hyperglycemia in the perioperative period deserve formal testing for the presence of diabetes and abnormal glucose metabolism.
Hyperglycemia has been previously linked to increased nosocomial infections among diabetics. 7, 8, 21 In vitro, polymorphonuclear leukocytes from diabetics exhibit decreased adherence, 22 chemotaxis, 23, 24 phagocytosis, 25 and bacteriocidal activity. 24, 26, 27 Often these cellular functions are improved by insulin and better glycemic control, 22, 25, 26 suggesting a direct relation between the defect and elevated blood glucose. Similarly, improved glucose control in the perioperative period has been associated with 27 have shown that defects in cellular host functions may be induced in cells from normal individuals by subjecting them to hyperglycemia; yet, others 23 have not been able to demonstrate this interaction, raising questions about the specific role of hyperglycemia in altering immune functions. Certainly, the findings in this report, in which postoperative hyperglycemia was an independent risk factor for development of SSI and the risk of infection correlated with the degree of hyperglycemia, are consistent with a direct effect of elevated glucose on immune mechanisms.
A large proportion of diabetic patients admitted to our institution for cardiothoracic surgery have poorly controlled diabetes; over 40% had hemoglobin A1c values of у8%. These patients are at increased risk of developing retinopathy, nephropathy, and microvascular complications. 9, 30 Moreover, the hyperglycemia and poor glucose control experienced by the known and undiagnosed diabetics may have contributed to the macrovascular complications that necessitated their admission to the hospital. 20, 31 Although elevated, the hemoglobin A1c values among diabetics were not associated with a statistically significant increased risk of infection, and glucose control in the perioperative period was an important risk factor for wound infections, whereas prolonged hyperglycemia in the month(s) prior to surgery was not. Diabetes also remained a risk factor for development of SSIs even after adjustment for the presence of hyperglycemia, suggesting that there are factors other than elevated glucose that predispose these patients to infections; these additional factors need to be better defined.
Most of the risk factors for development of SSIs noted in this and other reports [1] [2] [3] [4] [5] [6] are not alterable; gender, race, obesity, 2,4 chronic obstructive pulmonary disease, 2 and even duration of surgery are fixed obstacles to overcome. Hyperglycemia in the perioperative period is distinctly unique in this regard and potentially is easily controlled once identified. In this report, an abnormal hemoglobin A1c value was noted in only 58 (44%) of those without diabetes who ultimately developed hyperglycemia after surgery. This is poor sensitivity for a screening test. The 1998 to 1999 average excess cost attributable to one mediastinal infection at Saint Thomas Hospital was $50,986 (CST, oral communication, December 1998). The cost of a hemoglobin A1c determination during that time was $9. If the incidence of SSIs can be diminished by more intensive insulin therapy, as others have reported, 28, 29 early identification and careful treatment of those likely to develop postoperative hyperglycemia by screening with hemoglobin A1c determinations will be easily cost-effective despite the low sensitivity of the test. Moreover, patients would be identified who require more formal testing for diabetes and who, if the diagnosis is confirmed, would benefit from treatment to achieve primary prevention of microvascular complications in the future 32, 33 and secondary prevention of further macrovascular complications of the disease. [34] [35] [36] The benefits of these long-term preventive measures greatly enhance those attributable to prevention of infections and make screening for diabetes and abnormal glucose metabolism among nondiabetic patients with cardiovascular disease a worthwhile public health effort.
